Before the recent updates, I threw out there Cytodyn was

New Post Public Reply Private Reply Replies (0) Message Board
My69z
623
Before the recent updates, I threw out there Cytodyn was most likely not including the ICI in our CRC, to stay aligned with the Briefing Book section on past CRC, due to no past PD-L1 / ICI observations.

You don't request it in current CRC before Briefing acceptance. ICI is not our battle to fight, per say.

Dr. J has since commented he's excited that the Briefing has presented potential improvements to current CRC trial.

That surely sounds like he secured ICI influence / backing baked into the mix, to the FDA on our CRC / ICI.

Now add the Data Safety Committe can too recommend ICI @ any point, & Dr. J / team / Advisory Committee, have played the CRC protocol 100% correct.

Protocol adjustment is the easiest of the bigger picture

Expecting news of bumped to 700mg's any day. No news @ this point , means it's been approved.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Insider Purchases: Three Stocks Under $3 Worth Noting

Updated Category News Views 76

Executive Stock Purchases to Watch Recently, the Dow Jones index experienced a minor dip of about 0.2%. One important aspect of stock trading to pay attention to is insider activity—when company executives buy shares, it usually signals their confidence in the company's future. For anyone interested in penny stocks, these transactions can offer valuable insights for...

Continue Reading
Neoss Inc. Unveils Innovative NeoGenix Extraction Allograft

Updated Category News Views 213

Neoss Inc. Expands Biomaterials Portfolio Neoss Inc., a leader in innovative dental implant solutions, has exciting news for dental practitioners. They are proud to introduce the NeoGenix™ Extraction Allograft, a groundbreaking addition to their biomaterials line. This new product is crafted entirely from 100% human allograft bone fiber and bone particulate, aiming to...

Continue Reading
Brookdale Senior Living Shares Occupancy Insights for November

Updated Category News Views 137

Brookdale Senior Living's November 2024 Occupancy Report Brookdale Senior Living Inc. (NYSE: BKD) has officially released its occupancy figures for November 2024, showcasing the latest updates in their performance metrics. This report is crucial for understanding how the company is adapting to the ongoing dynamics of the senior living sector. Understanding the November...

Continue Reading
U.K. Stocks Experience Gains as Market Closes with Positive Signs

Updated Category News Views 102

U.K. Stocks Close Higher Amid Positive Market Trends The financial marketplace in the U.K. saw an uplifting close recently, showcasing a blend of strong performances across various sectors. Notably, the Mining, Household Goods, and General Industrial sectors significantly contributed to the upward momentum, indicating a healthful market environment. Sector Performances...

Continue Reading
Ember and Alfresa Join Forces on Pharma Cold Chain in Japan

Updated Category News Views 17

Strategic Partnerships for Future Growth Every now and then, an alliance pops up that makes investors like me perk up and pay attention. Today, it's Ember LifeSciences teaming up with Alfresa Corporation to shake up the pharmaceutical cold chain logistics scene in Japan. We're talking about a market that's buzzing with potential. This partnership isn't just a handshake...

Continue Reading